Primary open-angle glaucoma (POAG) is a chronic, progressive and irreversible eye disease. Currently, there is no effective way to prevent optic nerve damage.
Objective
This study explored POAG gene markers to identify high-risk groups at an early stage and to find new effective therapeutic targets.
Methods
The mRNA and clinical information of POAG patients and normal samples were downloaded from the Gene Expression Omnibus (GEO) database. Through Weighted correlation network analysis (WGCNA) and generalized linear models (GLM), random forests (RF), support vector machines (SVM), and extreme gradient boosting (xGB) models, key risk genes were identified and an early diagnosis model was established. Functional enrichment analysis and CIBERSORT algorithm were used to further reveal the changes in the POAG immune environment and find emerging therapeutic targets.
Results
HERPUD1, IQCK, MRPL40, SRSF7 and TMEM243 were identified as risk genes, and the prediction model and nomogram constructed based on them had good early prediction efficiency. At the mechanistic level, the heterogeneity of T cell subsets seems to be a key factor affecting the progression of POAG and has potential therapeutic value.
Conclusions: HERPUD1, IQCK, MRPL40, SRSF7, and TMEM243 are of great significance for the early prediction and disease progression of POAG and have the potential value of becoming therapeutic targets.
GeddeSJ, Vinod K, Wright MM, et al.Primary open-angle glaucoma preferred practice pattern®. Ophthalmology2021; 128: P71–p150.
2.
SteinJDKhawajaAPWeizerJS. Glaucoma in adults-screening, diagnosis, and management: a review. Jama2021; 325: 164–174.
3.
VoigtAM, Grabitz S, Hoffmann EM, et al.Systemic diseases in primary open-angle glaucoma. Klin Monbl Augenheilkd2024; 241: 170–176.
4.
MarshallHN, Mullany S, Han X, et al.High polygenic risk is associated with earlier initiation and escalation of treatment in early primary open-angle glaucoma. Ophthalmology2023; 130: 830–836.
5.
JayaramH, Kolko M, Friedman DS, et al.Glaucoma: now and beyond. Lancet2023; 402: 1788–1801.
HamelAR, Yan W, Rouhana JM, et al.Integrating genetic regulation and single-cell expression with GWAS prioritizes causal genes and cell types for glaucoma. Nat Commun2024; 15: 396.
8.
BaudouinC, Kolko M, Melik-Parsadaniantz S, et al.Inflammation in glaucoma: from the back to the front of the eye, and beyond. Prog Retin Eye Res2021; 83: 100916.
9.
FanW, Li W, Duan C, et al.Characterization of a novel mutation in the MYOC gene in a Chinese family with primary open–angle glaucoma. Mol Med Rep2020; 22: 3263–3270.
10.
Lopez-MartinezF, Lopez-Garrido MP, Sanchez-Sanchez F, et al.Role of MYOC and OPTN sequence variations in spanish patients with primary open-angle glaucoma. Mol Vis2007; 13: 862–872.
11.
Calero-DueñasN, Mateos-Olivares M, Ussa F, et al.Polymorphisms in CYP1B1 gene and the risk of suffering primary open-angle glaucoma: systematic review and meta-analysis. Eur J Ophthalmol2022; 32: 1841–1849.
12.
PasqualeLR. Vascular and autonomic dysregulation in primary open-angle glaucoma. Curr Opin Ophthalmol2016; 27: 94–101.
VernazzaS, Tirendi S, Bassi AM, et al.Neuroinflammation in Primary Open-Angle Glaucoma. J Clin Med2020; 9: 3172.
15.
WangL, Yu T, Zhang X, et al.Network integration analysis and immune infiltration analysis reveal potential biomarkers for primary open-angle glaucoma. Front Cell Dev Biol2021; 9: 793638.
16.
ZhangD, Wu J, Zhang S, et al.Identification of immune infiltration-related ceRNAs as novel biomarkers for prognosis of patients with primary open-angle glaucoma. Front Genet2022; 13: 838220.
17.
XuW, Sun Y, Zhao S, et al.Identification and validation of autophagy-related genes in primary open-angle glaucoma. BMC Med Genomics2023; 16: 287.
18.
Diaz-TorresS, He W, Thorp J, et al.Disentangling the genetic overlap and causal relationships between primary open-angle glaucoma, brain morphology and four major neurodegenerative disorders. EBioMedicine2023; 92: 104615.
19.
WashingtonJRitchRLiuY. Homocysteine and Glaucoma. Int J Mol Sci2023; 24: 10790.
20.
CiociolaECKliftoMR. Juvenile open angle glaucoma: current diagnosis and management. Curr Opin Ophthalmol2022; 33: 97–102.
21.
KathirvelK, Lester K, Haribalaganesh R, et al.Short and long-term effect of dexamethasone on the transcriptome profile of primary human trabecular meshwork cells in vitro. Sci Rep2022; 12: 8299.
22.
KompassKS, Agapova OA, Li W, et al.Bioinformatic and statistical analysis of the optic nerve head in a primate model of ocular hypertension. BMC Neurosci2008; 9: 93.
23.
LuS, Li Y, Wang L, et al.Effects of Herpud1 in Methamphetamine-Induced Neuronal Apoptosis. Curr Med Chem2024.
24.
Américo-Da-SilvaL, Diaz J, Bustamante M, et al.A new role for HERPUD1 and ERAD activation in osteoblast differentiation and mineralization. Faseb J2018; 32: 4681–4695.
25.
ShabanMS, Müller C, Mayr-Buro C, et al.Multi-level inhibition of coronavirus replication by chemical ER stress. Nat Commun2021; 12: 5536.
26.
WangH, Devadoss D, Nair M, et al.Novel Alzheimer risk factor IQ motif containing protein K is abundantly expressed in the brain and is markedly increased in patients with Alzheimer's disease. Front Cell Neurosci2022; 16: 954071.
27.
NussinovR, Zhang M, Tsai CJ, et al.Calmodulin and IQGAP1 activation of PI3Kα and akt in KRAS, HRAS and NRAS-driven cancers. Biochim Biophys Acta Mol Basis Dis2018; 1864: 2304–2314.
28.
GokhaleA, Lee CE, Zlatic SA, et al.Mitochondrial proteostasis requires genes encoded in a neurodevelopmental syndrome locus. J Neurosci2021; 41: 6596–6616.
29.
CheongALingutlaRMagerJ. Expression analysis of mammalian mitochondrial ribosomal protein genes. Gene Expr Patterns2020; 38: 119147.
30.
KönigsV, de Oliveira Freitas Machado C, Arnold B, et al.SRSF7 Maintains its homeostasis through the expression of split-ORFs and nuclear body assembly. Nat Struct Mol Biol2020; 27: 260–273.
31.
CunY, An S, Zheng H, et al.Specific regulation of m(6)A by SRSF7 promotes the progression of glioblastoma. Genomics Proteomics Bioinformatics2023; 21: 707–728.
32.
HongJ, Min S, Yoon G, et al.SRSF7 Downregulation induces cellular senescence through generation of MDM2 variants. Aging (Albany NY). 2023; 15: 14591–14606.
33.
GenoveseI, Ilari A, Assaraf YG, et al.Not only P-glycoprotein: amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins. Drug Resist Updat2017; 32: 23–46.
34.
DormanSN, Baranova K, Knoll JH, et al.Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning. Mol Oncol2016; 10: 85–100.
35.
YangX, Zeng Q, Göktas E, et al.T-Lymphocyte subset distribution and activity in patients with glaucoma. Invest Ophthalmol Vis Sci2019; 60: 877–888.
36.
YangJ, Patil RV, Yu H, et al.T cell subsets and sIL-2R/IL-2 levels in patients with glaucoma. Am J Ophthalmol2001; 131: 421–426.
37.
BellK, Holz A, Ludwig K, et al.Elevated regulatory T cell levels in glaucoma patients in comparison to healthy controls. Curr Eye Res2017; 42: 562–567.
38.
PanduroMBenoistCMathisD. Tissue tregs. Annu Rev Immunol2016; 34: 609–633.
39.
Burgos-BlascoB, Vidal-Villegas B, Saenz-Frances F, et al.Tear and aqueous humour cytokine profile in primary open-angle glaucoma. Acta Ophthalmol2020; 98: e768–e772.
40.
KarahanMKilicDGuvenS. Systemic inflammation in both open-angle and angle-closure glaucoma: role of platelet-to-lymphocyte ratio. Bratisl Lek Listy2021; 122: 45–48.
41.
WongM, Huang P, Li W, et al.T-helper1/T-helper2 cytokine imbalance in the iris of patients with glaucoma. PLoS One2015; 10: e0122184.
